Abstract:Background: Hepatocellular carcinoma (HCC) is a highly aggressive cancer with limited therapeutic options. Hypoxia is a common feature of the tumor microenvironment that reportedly promotes tumorigenesis. Long non-coding RNAs (lncRNAs) are a class of regulatory molecules with diverse functions in cancer biology. This study aimed to identify hypoxia-induced lncRNAs associated with HCC and evaluate their potential as prognostic and therapeutic biomarkers. Methods: We employed microarray and The Cancer Genome Atlas (TCGA) data to identify hypoxia-induced lncRNAs in HCC. Subsequently, we focused on CTD-2510F5.4, a candidate lncRNA, and predicted its functional roles in HCC using Gene Ontology (GO) and Guilt-by-Association (GBA) analyses. We validated its expression under hypoxia in Huh7 and HepG2 cells using RT-PCR. Functional assays, including CCK8, wound-healing, and transwell assays, were performed to assess the effects of CTD-2510F5.4 overexpression on HCC cell proliferation, invasion, and metastasis potential. Furthermore, we investigated the association between CTD-2510F5.4 expression and patient prognosis, tumor mutation signature, immune microenvironment characteristics, and therapeutic response to different treatment modalities. Results: Our data demonstrated a significant upregulation of CTD-2510F5.4 expression in response to hypoxia. Functional enrichment analyses revealed the involvement of CTD-2510F5.4 in cell cycle regulation, E2F targets, G2M checkpoint control, and MYC signaling pathways. Functionally, CTD-2510F5.4 overexpression promoted HCC cell proliferation, invasion, and metastasis. Patients with high CTD-2510F5.4 expression exhibited a worse prognosis, a higher prevalence of TP53 mutations, increased infiltration by immunosuppressive regulatory T cells, elevated expression of immune checkpoint molecules, and higher TIDE scores indicative of immune dysfunction and exclusion. Notably, patients with low CTD-2510F5.4 expression displayed greater sensitivity to immunotherapy and antiangiogenic therapy, while those with high expression responded better to chemotherapy. Conclusion: Our findings suggest that CTD-2510F5.4 plays a critical role in HCC progression and immune modulation. Its potential as a prognostic biomarker and a predictor of therapeutic response warrants further investigation for personalized treatment strategies in HCC patients.

Hypoxia-sensitive long noncoding RNA CASC15 promotes lung tumorigenesis by regulating the SOX4/β-catenin axis

Long noncoding RNA CASC15 is upregulated in non-small cell lung cancer and facilitates cell proliferation and metastasis via targeting miR-130b-3p.

Positive Feedback Regulation of Circular RNA Hsa_circ_0000566 and HIF-1α Promotes Osteosarcoma Progression and Glycolysis Metabolism.

Long Non-Coding RNA CASC15 is Upregulated in Hepatocellular Carcinoma and Facilitates Hepatocarcinogenesis.

LncRNA CASC15 Functions As an Oncogene by Sponging Mir-130B-3p in Bladder Cancer.

CASC15 Contributes to Proliferation and Invasion Through Regulating Mir-766-5p/ KLK12 Axis in Lung Cancer.

Long-Noncoding RNA CASC9 Promotes Progression of Non-Small Cell Lung Cancer by Promoting the Expression of CDC6 Through Binding to HuR

Ott_a_226078 9017..9027

Long Non-Coding RNA CASC9 And HIF-1α Form A Positive Feedback Loop To Facilitate Cell Proliferation And Metastasis In Lung Cancer

Higher Lncrna CASC15 Expression Predicts Poor Prognosis and Associates with Tumor Growth in Cervical Cancer.

Hypoxia-induced Lncrna CASC9 Enhances Glycolysis and the Epithelial-Mesenchymal Transition of Pancreatic Cancer by a Positive Feedback Loop with AKT/HIF-1α Signaling.

Lncrna Casc15 Promotes Colon Cancer Cell Proliferation And Metastasis By Regulating The Mir-4310/Lgr5/Wnt/Beta-Catenin Signaling Pathway

Long Noncoding RNA CASC9.5 Promotes the Proliferation and Metastasis of Lung Adenocarcinoma

CASC21, a FOXP1 Induced Long Non-Coding RNA, Promotes Colorectal Cancer Growth by Regulating CDK6.

Hypoxia-induced LINC00674 facilitates hepatocellular carcinoma progression by activating the NOX1/mTOR signaling pathway.

A Novel Hypoxia-Induced Lncrna, SZT2-AS1, Boosts HCC Progression by Mediating HIF Heterodimerization and Histone Trimethylation under a Hypoxic Microenvironment

Hypoxia-driven lncRNA CTD-2510F5.4: a potential player in hepatocellular carcinoma's prognostic stratification, cellular behavior, tumor microenvironment, and therapeutic response

LncRNA CASC15 is Upregulated in Osteosarcoma Plasma Exosomes and CASC15 Knockdown Inhibits Osteosarcoma Progression by Regulating miR-338-3p/RAB14 Axis

Long non‐coding RNA CASC19 facilitates non‐small cell lung cancer cell proliferation and metastasis by targeting the miR‐301b‐3p/LDLR axis

LncRNA CASC15, MiR-23b Cluster and SMAD3 Form a Novel Positive Feedback Loop to Promote Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer

Hypoxia Induced Lnc191 Upregulation Dictates the Progression of Esophageal Squamous Cell Carcinoma by Activating GRP78/ERK Pathway.